Clinical Trials in New York

Showing 15641-15660 of 22,668 trials

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

NCT00006025

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of temozolomide plus irinotecan in treating patients who have recurrent malignant glioma.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsStarted Jan 2001

Los Angeles, California, United States • San Francisco, California, United States • Bethesda, Maryland, United States +6 more locations

TERMINATED< 1 mile

A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study

NCT02356614

This is a post-approval, multicenter, prospective, non-randomized, open-label, clinical study to evaluate the safety and effectiveness of the LAP-BAND® AP System in a lower obese population (BMI ≥ 30 kg/m2 and \< 40 kg/m2) with one or more obesity-related comorbidity up to 10 years after implantation. The reason your study has been terminated is based on the availability of long-term safety and effectiveness data from the OSB Lead-HERo-002 study and published literature.

ObesityOverweight

Apollo Endosurgery, Inc.325 participantsStarted Mar 2015

Fountain Valley, California, United States • Champaign, Illinois, United States • Chicago, Illinois, United States +8 more locations

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study

Find Trials by Condition in New York

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons

A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

Efficacy of Group Attachment Based Intervention for Vulnerable Families

Orphenadrine and Methocarbamol for LBP

Decision Support for Smoking Cessation in Young Adults With Severe Mental Illness

An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas

ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

COOL-ARREST Pilot Study to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel

Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets